Peripheral Vascular Devices Market by Product (Balloon Inflation Devices, Catheters, Grafts), Technology Type (Minimally Invasive Surgeries, Open Surgery), Material Type, Indication, Patient Types, End-User - Global Forecast 2025-2032
Description
The Peripheral Vascular Devices Market was valued at USD 14.66 billion in 2024 and is projected to grow to USD 15.50 billion in 2025, with a CAGR of 6.19%, reaching USD 23.72 billion by 2032.
Setting the Stage for Advances in Peripheral Vascular Devices Amidst Evolving Clinical Needs and Technological Breakthroughs in Modern Healthcare
Peripheral vascular devices represent a cornerstone of modern vascular care, addressing an array of pathologies from peripheral artery disease to chronic venous insufficiency. Recent years have witnessed a surge in demand driven by aging populations, rising comorbidities, and shifting clinical paradigms that favor less invasive, more patient-friendly interventions. Innovations in stent design, from self-expanding nitinol frameworks to balloon-expandable variants, now coexist alongside advanced graft materials, closure mechanisms, and plaque modification tools. The collective momentum underscores the critical need for nuanced strategic analysis, integrating insights across clinical efficacy, material science, and health economics.
Moreover, the interplay between reimbursement models and supply chain optimization is reshaping commercial strategies. Manufacturers are tasked with harmonizing global production footprints while navigating distinct regulatory pathways and payer frameworks in each geography. This dual challenge has elevated the importance of robust evidence generation and localized engagement. Consequently, stakeholders must reconcile the pursuit of broad market access with the imperative to demonstrate real-world outcomes. This executive summary synthesizes the most impactful trends, competitive moves, and regulatory shifts, equipping decision-makers with the clarity necessary to drive innovation and capture value in an increasingly complex environment.
Unraveling the Key Drivers Redefining Peripheral Vascular Device Innovation and Adoption in Response to Shifting Clinical Protocols and Patient Demands
The landscape of peripheral vascular device development is being fundamentally redefined by a convergence of clinical, technological, and regulatory forces. Minimally invasive surgeries have accelerated in prominence, propelled by refinements in angioplasty and stenting techniques that reduce procedural risk and shorten recovery timelines. At the same time, open surgical methods such as bypass surgery and endarterectomy continue to be optimized through enhanced imaging guidance and hybrid operating environments, bridging the gap between traditional and contemporary approaches.
Technological integration is another transformative vector. Digital platforms are embedding real-time data analytics into catheter and closure device applications, enabling remote monitoring of hemodynamic parameters and enhancing post-procedure follow-up. Meanwhile, advances in material engineering-spanning cobalt chromium alloys to polymeric scaffolds-are delivering devices that exhibit improved biocompatibility and mechanical resilience. Regulatory authorities have responded by streamlining certain approval pathways, fostering accelerated access programs for breakthrough innovations while reinforcing post-market surveillance. Together, these shifts underscore a market in flux, where clinical efficacy, patient experience, and regulatory agility coalesce to set new benchmarks for success.
Analyzing the Cumulative Consequences of United States Tariff Adjustments on Peripheral Vascular Device Supply Chains Cost Structures and Strategic Responses
The onset of United States tariff adjustments scheduled for 2025 has cast a new light on peripheral vascular device supply chains and cost structures. As duties on key components and finished devices rise, manufacturers face the immediate challenge of preserving margin integrity without undermining access. Import dependencies for metal alloys such as nitinol and stainless steel, critical for stent and guidewire production, have become a focal point for strategic sourcing. Many organizations are now evaluating near-shoring, dual-sourcing, and localized assembly to reduce exposure and maintain pricing stability.
Furthermore, the cumulative nature of these tariffs creates downstream effects on distribution partners and healthcare providers, who must reconcile higher procurement costs with tightening reimbursement ceilings. In response, some device makers are adopting value-based contracting models, aligning pricing to patient outcomes and fostering risk-sharing arrangements with payers. Research and development roadmaps are also being recalibrated, with a renewed emphasis on material efficiency and modular designs that simplify production workflows. Ultimately, the tariff environment is not merely a cost headwind; it is catalyzing a strategic realignment toward more resilient, cost-effective operating models that can withstand future policy shifts.
Illuminating Market Segmentation Dynamics Across Product Technology Material Indication Patient Type and End-User Dimensions to Drive Strategic Positioning
A nuanced understanding of market segmentation is essential for crafting targeted growth strategies in the peripheral vascular device arena. On the product front, the field spans balloon inflation devices, a spectrum of catheter variations-from long peripheral intravenous catheters to midline and short peripheral intravenous catheters-and an array of stents that includes both balloon-expandable and self-expanding platforms. This product diversity extends to graft solutions, differentiated by biological, ePTFE, and polyester materials, as well as introducers, inferior vena cava filters, guidewires, plaque modification technologies, and vascular closure systems, each with distinct clinical value propositions.
Technology type further bifurcates the market into minimally invasive surgeries, notably angioplasty and stenting, and open surgical techniques such as bypass surgery and endarterectomy. Material composition introduces another layer of complexity, with metal devices leveraging cobalt chromium, nitinol, and stainless steel alloys, while non-metal alternatives employ polymer or silicone constructs. Indication-based segmentation distinguishes functional conditions-chronic venous insufficiency, Raynaud’s disease, varicose veins-from occlusive pathologies including atherosclerosis, Buerger’s disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient populations encompass adult and geriatric cohorts managing both acute and chronic presentations, alongside pediatric groups confronting acquired or congenital vascular anomalies. Finally, the end-user dimension identifies ambulatory surgical centers, clinics, and hospitals as the primary channels through which these devices are deployed, underscoring the need for tailored distribution, training, and support models.
Exploring Regional Nuances in Peripheral Vascular Device Uptake Across Americas Europe Middle East & Africa and Asia-Pacific Regulatory Environments
Regional disparities exert profound influence on peripheral vascular device adoption and commercialization strategies. In the Americas, well-established reimbursement frameworks and a robust network of interventional cardiology and radiology centers have created fertile ground for advanced minimally invasive procedures. Investment in health infrastructure and a growing emphasis on outpatient care are catalyzing demand for devices that deliver procedural efficiency and enhanced patient throughput.
Europe, the Middle East, and Africa present a mosaic of regulatory regimes and payer systems. The European Union’s unified CE marking facilitates cross-border market entry, yet national pricing controls and health technology assessments demand rigorous real-world evidence. Meanwhile, emerging markets in the Middle East and Africa are characterized by rapid hospital expansion and a focus on capacity building, creating opportunities for cost-effective graft and catheter solutions.
Asia-Pacific stands out for its dynamic growth trajectory, driven by expanding healthcare budgets in China, India, and Southeast Asia. Local manufacturing incentives, paired with regulatory bodies that increasingly align with global standards, are enabling accelerated product launches. However, stakeholders must navigate variable import regulations and channel partner ecosystems to fully capitalize on the region’s potential.
Deciphering Competitive Landscapes by Profiling Leading Peripheral Vascular Device Manufacturers Their Strategic Innovations and Collaborative Growth Initiatives
Market leadership in the peripheral vascular device sector is concentrated among a handful of global enterprises that combine extensive R&D capabilities with expansive distribution networks. These industry frontrunners have systematically expanded their portfolios, introducing next-generation drug-eluting and bioresorbable stent technologies alongside advanced vascular closure and plaque modification platforms. Collaborative alliances with digital health firms have also emerged, enabling integrated solutions that enhance procedural planning and patient monitoring.
Concurrently, mid-tier manufacturers and specialized innovators are carving out niches by focusing on cost-efficient catheter systems and novel graft materials. Their agility in navigating clinical trial requirements and responsive regulatory submissions has allowed them to address unmet needs in both developed and emerging markets. Partnerships with regional contract manufacturers accelerate time-to-market, while targeted licensing agreements facilitate rapid scale-up. Collectively, these competitive dynamics underscore the importance of both breadth and depth of capability, as enterprises strive to balance the pursuit of comprehensive product suites with the delivery of precise clinical differentiation.
Strategic Imperatives for Industry Stakeholders to Leverage Emerging Trends Mitigate Risks and Accelerate Growth in Peripheral Vascular Device Market
To thrive in a market defined by technological upheaval and policy complexity, industry stakeholders must adopt a multifaceted strategic playbook. Prioritizing portfolio diversification across key product categories-stents, catheters, grafts, and closure devices-can mitigate dependency on any single line and capture cross-segment synergies. Concurrently, investing in local manufacturing or assembly facilities reduces vulnerability to tariff fluctuations and enhances responsiveness to regional regulatory requirements.
Deepening engagement with payers through innovative value-based contracting models can align reimbursement with demonstrated patient outcomes, reinforcing the case for premium technologies. Additionally, fostering partnerships across digital health ecosystems will unlock novel revenue streams while improving clinical follow-up and adherence. From a commercialization perspective, customizing training programs and support services for ambulatory surgical centers, clinics, and hospitals ensures high utilization rates and positive procedural experiences. By integrating these imperatives into a cohesive roadmap, organizations can convert emerging trends into sustainable competitive advantage.
Outlining Rigorous Hybrid Methodology Integrating Primary Expert Interviews Secondary Data Review and Triangulation to Validate Market Insights
The foundation of this analysis rests on a hybrid methodology designed to deliver both breadth and depth. Secondary research encompassed comprehensive reviews of peer-reviewed publications, regulatory filings, patent databases, and trade association reports, ensuring a robust contextual framework. Primary research involved structured interviews with key opinion leaders in interventional cardiology, vascular surgery, and health economics, supplemented by dialogues with senior executives from device manufacturers, distributors, and clinical end-users.
Data synthesis employed triangulation techniques, cross-validating insights from quantitative sources-such as clinical trial registries and procedural volume data-with qualitative perspectives. This approach enabled the identification of convergent themes and the isolation of potential blind spots. Finally, proprietary analytical models were applied to map competitive positioning, regulatory impacts, and supply chain vulnerabilities, ensuring that conclusions reflect both empirical evidence and strategic foresight.
Synthesizing Findings to Chart a Forward-Looking Vision for Peripheral Vascular Device Innovation Market Leadership and Strategic Advancement
The collective insights presented in this executive summary underscore a peripheral vascular device market at a pivotal juncture. Technological innovations, from advanced alloy frameworks to digitally augmented catheter systems, are reshaping clinical possibilities, while evolving regulatory policies and tariff regimes demand adaptive strategies. Regional disparities further accentuate the need for localized approaches to reimbursement, manufacturing, and distribution.
Going forward, sustained success will depend on the ability to synthesize these multidimensional forces into coherent action plans. Companies that balance portfolio breadth with targeted clinical evidence, fortify supply chain resilience, and cultivate payer partnerships will be best positioned to lead. As the market continues to mature, stakeholders must remain vigilant, leveraging data-driven insights and collaborative innovation to chart a growth trajectory that is both resilient and transformative.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product
Balloon Inflation Devices
Catheters
Long Peripheral Intravenous Catheters
Midline Catheters
Short Peripheral Intravenous Catheter
Grafts
Biological Grafts
ePTFE Grafts
Polyester Grafts
Guidewires
Inferior Vena Cava Filters
Introducers
Plaque Modification Devices
Stents
Balloon-Expandable Stents
Self-Expanding Stents
Vascular Closure Devices
Technology Type
Minimally Invasive Surgeries
Angioplasty
Stenting
Open Surgery
Bypass Surgery
Endarterectomy
Material Type
Metal Devices
Cobalt Chromium
Nitinol
Stainless Steel
Non-Metal Devices
Polymer
Silicone
Indication
Functional Peripheral Vascular Disease
Chronic Venous Insufficiency
Raynaud's Disease
Varicose Veins
Occlusive Peripheral Vascular Disease
Atherosclerosis
Buerger’s Disease
Carotid Artery Disease
Deep Vein Thrombosis
Lymphedema
Patient Types
Adult & Geriatric
Acute Conditions
Chronic Conditions
Pediatric
Acquired Conditions
Congenital Conditions
End-User
Ambulatory Surgical Centers
Clinics
Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Abbott Laboratories
AngioDynamics, Inc.
Argon Medical Devices, Inc.
ASAHI INTECC CO., LTD
B. Braun SE
Baxter International Inc.
Becton, Dickinson and Company
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Esaote S.p.A.
FUJIFILM Holdings Corporation
GE HealthCare
Kimal PLC
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic PLC
Merit Medical Systems, Inc.
Nipro Corporation
Penumbra, Inc.
Sahajanand Medical Technologies Limited
Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
Siemens Healthineers AG
Summa Therapeutics, LLC
Teleflex Incorporated
Terumo Corporation
W. L. Gore & Associates, Inc.
Please Note: PDF & Excel + Online Access - 1 Year
Setting the Stage for Advances in Peripheral Vascular Devices Amidst Evolving Clinical Needs and Technological Breakthroughs in Modern Healthcare
Peripheral vascular devices represent a cornerstone of modern vascular care, addressing an array of pathologies from peripheral artery disease to chronic venous insufficiency. Recent years have witnessed a surge in demand driven by aging populations, rising comorbidities, and shifting clinical paradigms that favor less invasive, more patient-friendly interventions. Innovations in stent design, from self-expanding nitinol frameworks to balloon-expandable variants, now coexist alongside advanced graft materials, closure mechanisms, and plaque modification tools. The collective momentum underscores the critical need for nuanced strategic analysis, integrating insights across clinical efficacy, material science, and health economics.
Moreover, the interplay between reimbursement models and supply chain optimization is reshaping commercial strategies. Manufacturers are tasked with harmonizing global production footprints while navigating distinct regulatory pathways and payer frameworks in each geography. This dual challenge has elevated the importance of robust evidence generation and localized engagement. Consequently, stakeholders must reconcile the pursuit of broad market access with the imperative to demonstrate real-world outcomes. This executive summary synthesizes the most impactful trends, competitive moves, and regulatory shifts, equipping decision-makers with the clarity necessary to drive innovation and capture value in an increasingly complex environment.
Unraveling the Key Drivers Redefining Peripheral Vascular Device Innovation and Adoption in Response to Shifting Clinical Protocols and Patient Demands
The landscape of peripheral vascular device development is being fundamentally redefined by a convergence of clinical, technological, and regulatory forces. Minimally invasive surgeries have accelerated in prominence, propelled by refinements in angioplasty and stenting techniques that reduce procedural risk and shorten recovery timelines. At the same time, open surgical methods such as bypass surgery and endarterectomy continue to be optimized through enhanced imaging guidance and hybrid operating environments, bridging the gap between traditional and contemporary approaches.
Technological integration is another transformative vector. Digital platforms are embedding real-time data analytics into catheter and closure device applications, enabling remote monitoring of hemodynamic parameters and enhancing post-procedure follow-up. Meanwhile, advances in material engineering-spanning cobalt chromium alloys to polymeric scaffolds-are delivering devices that exhibit improved biocompatibility and mechanical resilience. Regulatory authorities have responded by streamlining certain approval pathways, fostering accelerated access programs for breakthrough innovations while reinforcing post-market surveillance. Together, these shifts underscore a market in flux, where clinical efficacy, patient experience, and regulatory agility coalesce to set new benchmarks for success.
Analyzing the Cumulative Consequences of United States Tariff Adjustments on Peripheral Vascular Device Supply Chains Cost Structures and Strategic Responses
The onset of United States tariff adjustments scheduled for 2025 has cast a new light on peripheral vascular device supply chains and cost structures. As duties on key components and finished devices rise, manufacturers face the immediate challenge of preserving margin integrity without undermining access. Import dependencies for metal alloys such as nitinol and stainless steel, critical for stent and guidewire production, have become a focal point for strategic sourcing. Many organizations are now evaluating near-shoring, dual-sourcing, and localized assembly to reduce exposure and maintain pricing stability.
Furthermore, the cumulative nature of these tariffs creates downstream effects on distribution partners and healthcare providers, who must reconcile higher procurement costs with tightening reimbursement ceilings. In response, some device makers are adopting value-based contracting models, aligning pricing to patient outcomes and fostering risk-sharing arrangements with payers. Research and development roadmaps are also being recalibrated, with a renewed emphasis on material efficiency and modular designs that simplify production workflows. Ultimately, the tariff environment is not merely a cost headwind; it is catalyzing a strategic realignment toward more resilient, cost-effective operating models that can withstand future policy shifts.
Illuminating Market Segmentation Dynamics Across Product Technology Material Indication Patient Type and End-User Dimensions to Drive Strategic Positioning
A nuanced understanding of market segmentation is essential for crafting targeted growth strategies in the peripheral vascular device arena. On the product front, the field spans balloon inflation devices, a spectrum of catheter variations-from long peripheral intravenous catheters to midline and short peripheral intravenous catheters-and an array of stents that includes both balloon-expandable and self-expanding platforms. This product diversity extends to graft solutions, differentiated by biological, ePTFE, and polyester materials, as well as introducers, inferior vena cava filters, guidewires, plaque modification technologies, and vascular closure systems, each with distinct clinical value propositions.
Technology type further bifurcates the market into minimally invasive surgeries, notably angioplasty and stenting, and open surgical techniques such as bypass surgery and endarterectomy. Material composition introduces another layer of complexity, with metal devices leveraging cobalt chromium, nitinol, and stainless steel alloys, while non-metal alternatives employ polymer or silicone constructs. Indication-based segmentation distinguishes functional conditions-chronic venous insufficiency, Raynaud’s disease, varicose veins-from occlusive pathologies including atherosclerosis, Buerger’s disease, carotid artery disease, deep vein thrombosis, and lymphedema. Patient populations encompass adult and geriatric cohorts managing both acute and chronic presentations, alongside pediatric groups confronting acquired or congenital vascular anomalies. Finally, the end-user dimension identifies ambulatory surgical centers, clinics, and hospitals as the primary channels through which these devices are deployed, underscoring the need for tailored distribution, training, and support models.
Exploring Regional Nuances in Peripheral Vascular Device Uptake Across Americas Europe Middle East & Africa and Asia-Pacific Regulatory Environments
Regional disparities exert profound influence on peripheral vascular device adoption and commercialization strategies. In the Americas, well-established reimbursement frameworks and a robust network of interventional cardiology and radiology centers have created fertile ground for advanced minimally invasive procedures. Investment in health infrastructure and a growing emphasis on outpatient care are catalyzing demand for devices that deliver procedural efficiency and enhanced patient throughput.
Europe, the Middle East, and Africa present a mosaic of regulatory regimes and payer systems. The European Union’s unified CE marking facilitates cross-border market entry, yet national pricing controls and health technology assessments demand rigorous real-world evidence. Meanwhile, emerging markets in the Middle East and Africa are characterized by rapid hospital expansion and a focus on capacity building, creating opportunities for cost-effective graft and catheter solutions.
Asia-Pacific stands out for its dynamic growth trajectory, driven by expanding healthcare budgets in China, India, and Southeast Asia. Local manufacturing incentives, paired with regulatory bodies that increasingly align with global standards, are enabling accelerated product launches. However, stakeholders must navigate variable import regulations and channel partner ecosystems to fully capitalize on the region’s potential.
Deciphering Competitive Landscapes by Profiling Leading Peripheral Vascular Device Manufacturers Their Strategic Innovations and Collaborative Growth Initiatives
Market leadership in the peripheral vascular device sector is concentrated among a handful of global enterprises that combine extensive R&D capabilities with expansive distribution networks. These industry frontrunners have systematically expanded their portfolios, introducing next-generation drug-eluting and bioresorbable stent technologies alongside advanced vascular closure and plaque modification platforms. Collaborative alliances with digital health firms have also emerged, enabling integrated solutions that enhance procedural planning and patient monitoring.
Concurrently, mid-tier manufacturers and specialized innovators are carving out niches by focusing on cost-efficient catheter systems and novel graft materials. Their agility in navigating clinical trial requirements and responsive regulatory submissions has allowed them to address unmet needs in both developed and emerging markets. Partnerships with regional contract manufacturers accelerate time-to-market, while targeted licensing agreements facilitate rapid scale-up. Collectively, these competitive dynamics underscore the importance of both breadth and depth of capability, as enterprises strive to balance the pursuit of comprehensive product suites with the delivery of precise clinical differentiation.
Strategic Imperatives for Industry Stakeholders to Leverage Emerging Trends Mitigate Risks and Accelerate Growth in Peripheral Vascular Device Market
To thrive in a market defined by technological upheaval and policy complexity, industry stakeholders must adopt a multifaceted strategic playbook. Prioritizing portfolio diversification across key product categories-stents, catheters, grafts, and closure devices-can mitigate dependency on any single line and capture cross-segment synergies. Concurrently, investing in local manufacturing or assembly facilities reduces vulnerability to tariff fluctuations and enhances responsiveness to regional regulatory requirements.
Deepening engagement with payers through innovative value-based contracting models can align reimbursement with demonstrated patient outcomes, reinforcing the case for premium technologies. Additionally, fostering partnerships across digital health ecosystems will unlock novel revenue streams while improving clinical follow-up and adherence. From a commercialization perspective, customizing training programs and support services for ambulatory surgical centers, clinics, and hospitals ensures high utilization rates and positive procedural experiences. By integrating these imperatives into a cohesive roadmap, organizations can convert emerging trends into sustainable competitive advantage.
Outlining Rigorous Hybrid Methodology Integrating Primary Expert Interviews Secondary Data Review and Triangulation to Validate Market Insights
The foundation of this analysis rests on a hybrid methodology designed to deliver both breadth and depth. Secondary research encompassed comprehensive reviews of peer-reviewed publications, regulatory filings, patent databases, and trade association reports, ensuring a robust contextual framework. Primary research involved structured interviews with key opinion leaders in interventional cardiology, vascular surgery, and health economics, supplemented by dialogues with senior executives from device manufacturers, distributors, and clinical end-users.
Data synthesis employed triangulation techniques, cross-validating insights from quantitative sources-such as clinical trial registries and procedural volume data-with qualitative perspectives. This approach enabled the identification of convergent themes and the isolation of potential blind spots. Finally, proprietary analytical models were applied to map competitive positioning, regulatory impacts, and supply chain vulnerabilities, ensuring that conclusions reflect both empirical evidence and strategic foresight.
Synthesizing Findings to Chart a Forward-Looking Vision for Peripheral Vascular Device Innovation Market Leadership and Strategic Advancement
The collective insights presented in this executive summary underscore a peripheral vascular device market at a pivotal juncture. Technological innovations, from advanced alloy frameworks to digitally augmented catheter systems, are reshaping clinical possibilities, while evolving regulatory policies and tariff regimes demand adaptive strategies. Regional disparities further accentuate the need for localized approaches to reimbursement, manufacturing, and distribution.
Going forward, sustained success will depend on the ability to synthesize these multidimensional forces into coherent action plans. Companies that balance portfolio breadth with targeted clinical evidence, fortify supply chain resilience, and cultivate payer partnerships will be best positioned to lead. As the market continues to mature, stakeholders must remain vigilant, leveraging data-driven insights and collaborative innovation to chart a growth trajectory that is both resilient and transformative.
Market Segmentation & Coverage
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
Product
Balloon Inflation Devices
Catheters
Long Peripheral Intravenous Catheters
Midline Catheters
Short Peripheral Intravenous Catheter
Grafts
Biological Grafts
ePTFE Grafts
Polyester Grafts
Guidewires
Inferior Vena Cava Filters
Introducers
Plaque Modification Devices
Stents
Balloon-Expandable Stents
Self-Expanding Stents
Vascular Closure Devices
Technology Type
Minimally Invasive Surgeries
Angioplasty
Stenting
Open Surgery
Bypass Surgery
Endarterectomy
Material Type
Metal Devices
Cobalt Chromium
Nitinol
Stainless Steel
Non-Metal Devices
Polymer
Silicone
Indication
Functional Peripheral Vascular Disease
Chronic Venous Insufficiency
Raynaud's Disease
Varicose Veins
Occlusive Peripheral Vascular Disease
Atherosclerosis
Buerger’s Disease
Carotid Artery Disease
Deep Vein Thrombosis
Lymphedema
Patient Types
Adult & Geriatric
Acute Conditions
Chronic Conditions
Pediatric
Acquired Conditions
Congenital Conditions
End-User
Ambulatory Surgical Centers
Clinics
Hospitals
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
Americas
North America
United States
Canada
Mexico
Latin America
Brazil
Argentina
Chile
Colombia
Peru
Europe, Middle East & Africa
Europe
United Kingdom
Germany
France
Russia
Italy
Spain
Netherlands
Sweden
Poland
Switzerland
Middle East
United Arab Emirates
Saudi Arabia
Qatar
Turkey
Israel
Africa
South Africa
Nigeria
Egypt
Kenya
Asia-Pacific
China
India
Japan
Australia
South Korea
Indonesia
Thailand
Malaysia
Singapore
Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
Abbott Laboratories
AngioDynamics, Inc.
Argon Medical Devices, Inc.
ASAHI INTECC CO., LTD
B. Braun SE
Baxter International Inc.
Becton, Dickinson and Company
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cardinal Health, Inc.
Cook Group Incorporated
Esaote S.p.A.
FUJIFILM Holdings Corporation
GE HealthCare
Kimal PLC
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co., Ltd.
Medtronic PLC
Merit Medical Systems, Inc.
Nipro Corporation
Penumbra, Inc.
Sahajanand Medical Technologies Limited
Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
Siemens Healthineers AG
Summa Therapeutics, LLC
Teleflex Incorporated
Terumo Corporation
W. L. Gore & Associates, Inc.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
194 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Increasing adoption of drug-coated balloons to reduce restenosis in peripheral artery disease
- 5.2. Integration of artificial intelligence in imaging systems to enhance peripheral vascular intervention planning
- 5.3. Rising use of bioresorbable scaffolds to minimize long-term complications in peripheral vessels
- 5.4. Advancements in microcatheter technology to improve navigation through complex peripheral vasculature
- 5.5. Growing demand for portable vascular ultrasound devices for point-of-care lower limb assessments
- 5.6. Innovations in atherectomy devices for precise removal of peripheral arterial plaque
- 5.7. Expansion of telehealth remote monitoring solutions for post-procedural peripheral vascular patients
- 6. Cumulative Impact of United States Tariffs 2025
- 7. Cumulative Impact of Artificial Intelligence 2025
- 8. Peripheral Vascular Devices Market, by Product
- 8.1. Balloon Inflation Devices
- 8.2. Catheters
- 8.2.1. Long Peripheral Intravenous Catheters
- 8.2.2. Midline Catheters
- 8.2.3. Short Peripheral Intravenous Catheter
- 8.3. Grafts
- 8.3.1. Biological Grafts
- 8.3.2. ePTFE Grafts
- 8.3.3. Polyester Grafts
- 8.4. Guidewires
- 8.5. Inferior Vena Cava Filters
- 8.6. Introducers
- 8.7. Plaque Modification Devices
- 8.8. Stents
- 8.8.1. Balloon-Expandable Stents
- 8.8.2. Self-Expanding Stents
- 8.9. Vascular Closure Devices
- 9. Peripheral Vascular Devices Market, by Technology Type
- 9.1. Minimally Invasive Surgeries
- 9.1.1. Angioplasty
- 9.1.2. Stenting
- 9.2. Open Surgery
- 9.2.1. Bypass Surgery
- 9.2.2. Endarterectomy
- 10. Peripheral Vascular Devices Market, by Material Type
- 10.1. Metal Devices
- 10.1.1. Cobalt Chromium
- 10.1.2. Nitinol
- 10.1.3. Stainless Steel
- 10.2. Non-Metal Devices
- 10.2.1. Polymer
- 10.2.2. Silicone
- 11. Peripheral Vascular Devices Market, by Indication
- 11.1. Functional Peripheral Vascular Disease
- 11.1.1. Chronic Venous Insufficiency
- 11.1.2. Raynaud's Disease
- 11.1.3. Varicose Veins
- 11.2. Occlusive Peripheral Vascular Disease
- 11.2.1. Atherosclerosis
- 11.2.2. Buerger’s Disease
- 11.2.3. Carotid Artery Disease
- 11.2.4. Deep Vein Thrombosis
- 11.2.5. Lymphedema
- 12. Peripheral Vascular Devices Market, by Patient Types
- 12.1. Adult & Geriatric
- 12.1.1. Acute Conditions
- 12.1.2. Chronic Conditions
- 12.2. Pediatric
- 12.2.1. Acquired Conditions
- 12.2.2. Congenital Conditions
- 13. Peripheral Vascular Devices Market, by End-User
- 13.1. Ambulatory Surgical Centers
- 13.2. Clinics
- 13.3. Hospitals
- 14. Peripheral Vascular Devices Market, by Region
- 14.1. Americas
- 14.1.1. North America
- 14.1.2. Latin America
- 14.2. Europe, Middle East & Africa
- 14.2.1. Europe
- 14.2.2. Middle East
- 14.2.3. Africa
- 14.3. Asia-Pacific
- 15. Peripheral Vascular Devices Market, by Group
- 15.1. ASEAN
- 15.2. GCC
- 15.3. European Union
- 15.4. BRICS
- 15.5. G7
- 15.6. NATO
- 16. Peripheral Vascular Devices Market, by Country
- 16.1. United States
- 16.2. Canada
- 16.3. Mexico
- 16.4. Brazil
- 16.5. United Kingdom
- 16.6. Germany
- 16.7. France
- 16.8. Russia
- 16.9. Italy
- 16.10. Spain
- 16.11. China
- 16.12. India
- 16.13. Japan
- 16.14. Australia
- 16.15. South Korea
- 17. Competitive Landscape
- 17.1. Market Share Analysis, 2024
- 17.2. FPNV Positioning Matrix, 2024
- 17.3. Competitive Analysis
- 17.3.1. Abbott Laboratories
- 17.3.2. AngioDynamics, Inc.
- 17.3.3. Argon Medical Devices, Inc.
- 17.3.4. ASAHI INTECC CO., LTD
- 17.3.5. B. Braun SE
- 17.3.6. Baxter International Inc.
- 17.3.7. Becton, Dickinson and Company
- 17.3.8. BIOTRONIK SE & Co. KG
- 17.3.9. Boston Scientific Corporation
- 17.3.10. Cardinal Health, Inc.
- 17.3.11. Cook Group Incorporated
- 17.3.12. Esaote S.p.A.
- 17.3.13. FUJIFILM Holdings Corporation
- 17.3.14. GE HealthCare
- 17.3.15. Kimal PLC
- 17.3.16. Koninklijke Philips N.V.
- 17.3.17. Lepu Medical Technology (Beijing) Co., Ltd.
- 17.3.18. Medtronic PLC
- 17.3.19. Merit Medical Systems, Inc.
- 17.3.20. Nipro Corporation
- 17.3.21. Penumbra, Inc.
- 17.3.22. Sahajanand Medical Technologies Limited
- 17.3.23. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
- 17.3.24. Siemens Healthineers AG
- 17.3.25. Summa Therapeutics, LLC
- 17.3.26. Teleflex Incorporated
- 17.3.27. Terumo Corporation
- 17.3.28. W. L. Gore & Associates, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
